Table 3.
Pre-KAS | Months Post-KAS | |||||||
---|---|---|---|---|---|---|---|---|
cPRA | 0-6 mos | 6-12 mos | 12-18 mos | 18-24 mos | 24-30 mos | 30-36 mos | P | |
80-89% | 2.693.273.97 | 0.971.261.64 | 1.031.261.55 | 1.111.381.71 | 1.321.642.04 | 1.351.662.04 | 1.501.792.14 | <0.001 |
90-97% | 1.011.191.40 | 0.911.261.75 | 1.041.331.70 | 1.111.481.96 | 1.241.682.29 | 1.271.752.29 | 1.431.822.32 | 0.006 |
98% | 0.350.440.55 | 0.671.001.45 | 0.520.831.31 | 0.761.161.77 | 0.731.141.76 | 0.751.121.68 | 0.650.941.36 | 0.33 |
99% | 0.240.290.35 | 1.161.622.27 | 1.121.532.10 | 0.981.482.23 | 1.191.782.65 | 1.281.782.48 | 1.191.682.38 | 0.97 |
99.5-99.9% | 0.100.120.15 | 2.753.795.22 | 2.673.604.87 | 2.193.184.61 | 2.543.615.12 | 2.573.645.15 | 2.463.504.98 | 0.85 |
99.9%+ | 0.020.030.04 | 0.290.390.53 | 0.320.430.57 | 0.270.340.43 | 0.290.390.53 | 0.220.320.46 | 0.290.400.56 | 0.15 |
Relative rates are presented as the relative rate of transplantation for a given cPRA category compared to cPRA 0-79%. P-values are testing for trends post-KAS within each cPRA category; significant values suggest transplant rates after KAS are changing over time. Bolded values represent a relative DDKT rate within that time period that is significantly different than 1 (p<0.05)
calculated panel reactive antibody
kidney allocation system
highly sensitized